Crystal structure and X-ray powder diffraction data for Lumateperone tosylate

Structure-based discovery of nonhallucinogenic psychedelic analogs

(2022) Dongmei Cao et al.   SCIENCE

Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism

(2022) J Titulaer et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

New Antipsychotic Medications in the Last Decade

(2021) Mehak Pahwa et al.   Current Psychiatry Reports

Lumateperone: First Approval

(2020) Hannah A. Blair   DRUGS

Lumateperone: A Novel Antipsychotic for Schizophrenia

(2020) Jessica Greenwood et al.   ANNALS OF PHARMACOTHERAPY

Evidence On The New Drug Lumateperone (Iti-007) For Psychiatric And Neurological Disorders

(2020) Marianna Mazza et al.   CNS & Neurological Disorders-Drug Targets

The Powder Diffraction File: a quality materials characterization database

(2019) Stacy Gates-Rector et al.   POWDER DIFFRACTION

The Cambridge Structural Database

(2016) Colin R. Groom et al.   Acta Crystallographica Section B-Structural Science Crystal Engineering and Materials

SHELXT– Integrated space-group and crystal-structure determination

(2015) George M. Sheldrick   Acta Crystallographica A-Foundation and Advances

Crystal structure refinement withSHELXL

(2015) George M. Sheldrick   Acta Crystallographica Section C-Structural Chemistry

OLEX2: a complete structure solution, refinement and analysis program

(2009) Oleg V. Dolomanov et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY